FDA Advisory Committee Votes To Recommend Novavax Covid-19 Vaccine
The Food and Drug Administration advisory committee unanimously voted 21-0 on Tuesday to recommend Novavax’s Covid-19 vaccination for emergency use in adults after a day-long meeting where they discussed data on safety and effectiveness. The FDA will likely follow the committee’s suggestion, in signing off on Novavax’s two doses. If they do, pharmacies and health care providers will be able to begin administering doses for the fourth FDA-approved vaccine in the U.S. The vaccine was developed differently than the other available vaccines. The technology in Novavax’s shots is more closely relate...